Next Article in Journal
Targeted Radionuclide Therapy: New Advances for Improvement of Patient Management and Response
Next Article in Special Issue
Clinical Outcomes of Conversion Surgery after Neoadjuvant Chemotherapy in Patients with Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer: A Single-Center, Retrospective Analysis
Previous Article in Journal
Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations
Previous Article in Special Issue
An Integrative Data Mining and Omics-Based Translational Model for the Identification and Validation of Oncogenic Biomarkers of Pancreatic Cancer
Article Menu
Issue 2 (February) cover image

Export Article

Open AccessArticle
Cancers 2019, 11(2), 267; https://doi.org/10.3390/cancers11020267

Preoperative Imaging Evaluation after Downstaging of Pancreatic Ductal Adenocarcinoma: A Multi-Center Study

1
Department of Radiology, G.B. Rossi Hospital, University of Verona, 37134 Verona, Italy
2
Department of Radiology, Istituto Oncologico Giovanni Paolo II, 70124 Bari, Italy
3
Department of Pathology, G.B. Rossi Hospital, University of Verona, 37134 Verona, Italy
4
Department of Radiology, G. Martino Hospital, University of Messina, 98125 Messina, Italy
5
Department of Radiology, Ospedale Generale Regionale “F. Miulli”, 70021 Acquaviva della Fonti, Italy
6
Department of Radiology, Ospedale P. Pederzoli, 37019 Peschiera del Garda, Italy
7
Department of Radiology, Ospedale Civile Maggiore Borgo Trento, Azienda Ospedaliera Universitaria Integrata, 37134 Verona, Italy
8
Department of Radiology, Ospedale “Sacro Cuore, Don Calabria”, 37024 Negrar, Italy
9
Department of Surgery, G.B. Rossi Hospital, University of Verona, 37134 Verona, Italy
*
Author to whom correspondence should be addressed.
Received: 20 January 2019 / Revised: 12 February 2019 / Accepted: 19 February 2019 / Published: 25 February 2019
(This article belongs to the Special Issue Advances in Pancreatic Cancer Research)
  |  
PDF [1764 KB, uploaded 25 February 2019]
  |  

Abstract

Introduction: Evaluation of pancreatic ductal adenocarcinoma (PDAC) after chemoradiotherapy downstaging is challenging due to computed tomography (CT) overestimation of tumor extension and residual vascular involvement, limiting access to surgery to some patients with potentially resectable tumors. With this study, we wanted to assess which radiological findings are most reliable at pre-operative imaging in the evaluation of PDAC after chemoradiotherapy in order to achieve complete resection. Methods: We retrospectively enrolled 71 patients with locally advanced and borderline resectable PDAC who underwent neoadjuvant chemoradiotherapy. Pre-operative CT or magnetic resonance (MR) have been evaluated by three radiologists to assess major qualitative and quantitative parameters of lesions. Accuracy, sensitivity, and specificity compared to anatomopathological results were evaluated for each parameter. Cohen’s K-coefficient has been calculated to evaluate the inter-observer agreement (IOA). Both single and consensus lecture have been tested. Different dimensional cut-offs were tested to categorize tumors according to their major axis and to compare with anatomopathological diameter, tumor persistence, and margin infiltration. Results: A 25 mm cut-off was 67% sensitive, 90% specific, and 77% accurate in assessing real tumor dimension. 25 mm cut-off reported a 64% sensitivity, 78% specificity, and 69% accuracy in assessing R0 resection. Each 5 mm increment of major axis dimension there is an odds ratio (OR) 1.79 (95% CI 1.13–2.80, p = 0.012) for R+ resection. Imaging presence of the perivascular cuff is not associated with tumor persistence and resection margin infiltration (p = 0.362). Lesion enhancement and pattern homogeneity were not accurate in determining tumor persistence. IOA was generally poor to fair, except for >25 mm cut-off classification where IOA was moderate. Diagnostic accuracy is superior in consensus lecture rather than single lecture. Conclusion: Imaging methods tend to underestimate PDAC resectability after neoadjuvant-CRT. IOA is poor to fair in evaluating most of the qualitative parameters of downstaged pancreatic adenocarcinoma. Surgery should be considered for downstaged borderline resectable PDACs, independently from perivascular cuff presence, especially for tumors smaller than 25 mm. View Full-Text
Keywords: pancreas; pancreatic cancer; adenocarcinoma; downstaging; CT; chemotherapy pancreas; pancreatic cancer; adenocarcinoma; downstaging; CT; chemotherapy
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Beleù, A.; Calabrese, A.; Rizzo, G.; Capelli, P.; Bellini, N.; Caloggero, S.; Calbi, R.; Tinazzi Martini, P.; De Robertis, R.; Carbognin, G.; Marchegiani, G.; Scarpa, A.; Salvia, R.; Bassi, C.; D’Onofrio, M. Preoperative Imaging Evaluation after Downstaging of Pancreatic Ductal Adenocarcinoma: A Multi-Center Study. Cancers 2019, 11, 267.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top